| Literature DB >> 26445136 |
Zekun Bao1, Xue Gao1, Qiang Zhang1, Jian Lin1, Weiwei Hu1, Huiqing Yu2, Jianquan Chen2, Qian Yang1, Qinghua Yu1.
Abstract
The development of genetically engineered animals has brought with it increasing concerns about biosafety issues. We therefore evaluated the risks of growth hormone from transgenic goats, including the probability of horizontal gene transfer and the impact on the microbial community of the goats' gastrointestinal tracts, feces and the surrounding soil. The results showed that neither the GH nor the neoR gene could be detected in the samples. Moreover, there was no significant change in the microbial community of the gastrointestinal tracts, feces and soil, as tested with PCR-denaturing gradient gel electrophoresis and 16S rDNA sequencing. Finally, phylogenetic analysis showed that the intestinal content, feces and soil samples all contained the same dominant group of bacteria. These results demonstrated that expression of goat growth hormone in the mammary of GH transgenic goat does not influence the microflora of the intestine, feces and surrounding soil.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26445136 PMCID: PMC4596820 DOI: 10.1371/journal.pone.0139822
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Detailed information about the goats.
| No. | Target gene | Promoter | Generation | Age (year) and Sex | Gene manipulation |
|---|---|---|---|---|---|
| 1 |
| beta-lactoglobulin | F0 | 3, female | SCNT |
| 2 |
| beta-lactoglobulin | F0 | 3, female | SCNT |
| 3 |
| beta-lactoglobulin | F0 | 3, female | SCNT |
| 4 |
| beta-lactoglobulin | F0 | 3, female | SCNT |
| 5 |
| beta-lactoglobulin | F1 | 2, female | Breeding |
| 6 |
| beta-lactoglobulin | F1 | 2, female | Breeding |
| 7 |
| beta-lactoglobulin | F1 | 2, female | Breeding |
| 8 |
| beta-lactoglobulin | F2 | 1, female | Breeding |
| 9 |
| beta-lactoglobulin | F2 | 1, female | Breeding |
| 10 |
| beta-lactoglobulin | F2 | 1, female | Breeding |
| 11–14 | None | None | - | 3, female | Control |
a 1–10: transgenic goats, 11–14: non-transgenic goats
b GH: growth hormone
c Our previous study provided the detailed sequence information
d SCNT: somatic cell nuclear transfer.
Feces, soil and intestinal content samples.
| Feces | Soil | Intestinal content | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample | Goat | Note | Sample | Goat | Distance from GH goat pen (m) | Sample | Goat | Location |
| S1 | 42007 | GH F0 | S5 | - | 0 | S9 | 4 | Jejunum |
| S2 | 42131 | GH F1 | S6 | - | 50 | S10 | 14 | Jejunum |
| S3 | 42226 | GH F2 | S7 | - | 100 | S11 | 4 | Cecum |
| S4 | 42321 | Control | S8 | - | 150 | S12 | 14 | Cecum |
1–10: transgenic goats, 11–14: non-transgenic goats.
Fig 1(A) Electrophoresis verification of the DNA extraction of samples. M: marker. (B) PCR results for the growth hormone gene detection experiment. NC: negative control with ddH2O. PC: positive control with pcGH vector over-expression. (C) PCR result of the neoR gene detection. NC: negative control with ddH2O. PC: positive control with over-expression of the pcGH vector. (D) PCR amplification of the 16 s rDNA of bacteria from samples.
Fig 2DGGE analysis of 16S rDNA fragments obtained after PCR amplification of the variable V3 region with universal primers 338F and 534R.
The DGGE profiles for the total microbial DNAs extracted from samples are shown. The samples are described in Table 2. The numbers in the figures indicate the DGGE bands selected for cloning and sequencing.
Fig 3Cluster analysis based on the UPGMA of the DGGE profiles of the feces (A), soil (B) and intestinal content (C) samples.
Scale bars indicate differences among the profiles.
Fig 4Phyla distribution of the 16S rDNA clone libraries obtained from the samples.